Contact Us
Interventional Oncology Global Market Report 2025
Global Interventional Oncology Market Report 2025
Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Interventional Oncology Global Market Report 2025

By Type (Radiation Therapy Devices, Ablation Devices, Embolization Devices), By Technology Type (Ultrasound, Computed Tomography Guided, Magnetic Resonance-Guided), By Procedure (Tumor Ablation, Tumor Biopsy, Vascular Interventions, Palliative Care), By Application Areas (Liver Cancer, Lung Cancer, Kidney Cancer, Pancreatic Cancer, Prostate Cancer), By End-Users (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutions) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Interventional Oncology Market Overview

• Interventional Oncology market size has reached to $2.49 billion in 2024

• Expected to grow to $3.82 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%

• Growth Driver: Increasing Prevalence Of Cancer Fueling The Growth Of The Market Due To Rising Lifestyle-Related Risk Factors And Growing Cancer Cases

• Market Trend: Innovative Catheter-Based Therapy Enhances Precision In Liver Cancer Treatment

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Interventional Oncology Market?

Interventional oncology is a medical specialty focused on minimally invasive, image-guided procedures to diagnose and treat cancer. Its primary purpose is to provide effective cancer treatment options with reduced recovery times and fewer side effects compared to traditional surgery.

The main types of interventional oncology are radiation therapy devices, ablation devices, and embolization devices. Radiation therapy devices are specialized medical equipment designed to deliver controlled doses of ionizing radiation to targeted areas in the body to treat cancer and other diseases by destroying or damaging abnormal cells while minimizing harm to surrounding healthy tissue. These devices utilize technologies such as ultrasound, computed tomography guidance, and magnetic resonance guidance, and the procedures performed include tumor ablation, tumor biopsy, vascular interventions, and palliative care. These treatments are applied to various cancers, including liver cancer, lung cancer, kidney cancer, pancreatic cancer, and prostate cancer, and cater to various end-users such as hospitals, ambulatory surgical centers, specialty clinics, and research and academic institutions.

Interventional Oncology Market Size and growth rate 2025 to 2029: Graph

What Is The Interventional Oncology Market Size 2025 And Growth Rate?

The interventional oncology market size has grown strongly in recent years. It will grow from $2.49 billion in 2024 to $2.72 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing incidence of cancer worldwide, rising adoption of minimally invasive procedures, increasing healthcare expenditure in emerging economies, rising demand for image-guided therapies, and increasing awareness of interventional oncology benefits.

What Is The Interventional Oncology Market Growth Forecast?

The interventional oncology market size is expected to see strong growth in the next few years. It will grow to $3.82 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to rising demand for outpatient oncology procedures, growing use of combination therapies with immuno-oncology, increasing clinical trials for image-guided therapies, increasing access to interventional oncology in emerging markets, and the growing role of precision medicine in treatment planning. Major trends in the forecast period include advancement in image-guided ablation technologies, development of artificial intelligence-powered diagnostic tools, innovation in targeted drug-delivery systems, advancement in minimally invasive treatment devices, and development of personalized oncology treatment solutions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Interventional Oncology Market Segmented?

1) By Type: Radiation Therapy Devices, Ablation Devices, Embolization Devices

2) By Technology Type: Ultrasound, Computed Tomography Guided, Magnetic Resonance-Guided

3) By Procedure: Tumor Ablation, Tumor Biopsy, Vascular Interventions, Palliative Care

4) By Application Areas: Liver Cancer, Lung Cancer, Kidney Cancer, Pancreatic Cancer, Prostate Cancer

5) By End-Users: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutions

Subsegments:

1) By Radiation Therapy Devices: Linear Accelerators, Proton Therapy Systems, Brachytherapy Devices

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Irreversible Electroporation Systems

3) By Embolization Devices: Microspheres, Coil Embolization Devices, Liquid Embolic Agents, Embolic Protection Devices

What Is Driving The Interventional Oncology Market? Increasing Prevalence Of Cancer Fueling The Growth Of The Market Due To Rising Lifestyle-Related Risk Factors And Growing Cancer Cases

The increasing prevalence of cancer is expected to propel the growth of the interventional oncology market going forward. Prevalence of cancer refers to the total number of people, both newly diagnosed and previously diagnosed, who are alive with a history of cancer at a specific point in time. The prevalence of cancer is increasing due to lifestyle-related risks such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, elevating the risk of developing various cancers. Interventional oncology aids in cancer treatment by providing minimally invasive, targeted therapies that focus directly on tumors. It improves patient outcomes by reducing damage to healthy tissue and offers faster recovery times compared to traditional treatments. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the number of cancer cases diagnosed in Australia reached 160,570 in 2022, marking an increase of 3,789 cases from 156,781 in 2021. Therefore, the increasing prevalence of cancer is driving the growth of the interventional oncology industry.

Who Are The Major Players In The Global Interventional Oncology Market?

Major companies operating in the interventional oncology market are Johnson & Johnson, Siemens Healthineers AG, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Hologic Inc., Teleflex Incorporated, Lantheus Holdings Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet S.A, Asahi Intecc Co. Ltd., AngioDynamics Inc., Sirtex Medical Limited., Delcath Systems Inc., ABK Biomedical Inc., Profound Medical Inc., IceCure Medical Ltd., Minimax Medical Holding Group.

What Are The Key Trends Of The Global Interventional Oncology Market? Innovative Catheter-Based Therapy Enhances Precision In Liver Cancer Treatment

Major companies operating in the interventional oncology market are focusing on developing advanced products, such as microcatheter-based embolization systems, to deliver precise, targeted cancer therapy while minimizing damage to surrounding healthy tissue. Microcatheter-based embolization systems refer to medical devices that use tiny, flexible catheters to deliver embolic agents precisely into blood vessels to block or reduce blood flow, typically for treating tumors, vascular malformations, or bleeding. For instance, in March 2025, Terumo Corporation, a Japan-based medical device company, launched the Occlusafe balloon occlusion catheter based on its advanced Balloon-TACE (B-TACE) therapy for the treatment of liver cancer, particularly hepatocellular carcinoma (HCC). This specialized microcatheter leverages the pressure gradient effect to redirect blood flow and access the microcirculation, enabling higher concentrations of therapeutic agents at the tumor site while minimizing off-target embolization. This targeted approach aims to improve clinical outcomes in difficult-to-treat liver cancer cases by enhancing drug delivery precision and offering improved visualization during procedures.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Interventional Oncology Market? Boston Scientific Acquires Obsidio To Enhance Interventional Oncology And Embolization Capabilities

In August 2022, Boston Scientific Corporation, a US-based medical device company, acquired Obsidio Inc. for an undisclosed amount. With this acquisition, Boston Scientific Corporation aims to strengthen its interventional oncology and embolization portfolio by adding a differentiated embolic technology that offers procedural efficiency and personalized therapy for patients. Obsidio Inc. is a US-based medical device company specializing in innovative solutions for interventional oncology.

What Is The Regional Outlook For The Global Interventional Oncology Market?

North America was the largest region in the interventional oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Interventional Oncology Market?

The interventional oncology market consists of revenues earned by entities by providing services such as image-guided tumor ablation, biopsy and diagnostic imaging, pain palliation procedures, and thermal ablation planning and follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional oncology market also includes sales of image-guided navigation systems, catheters and guidewires, radiation delivery systems, and biopsy needles and systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Interventional Oncology Industry?

The interventional oncology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the interventional oncology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Interventional Oncology Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.72 billion
Revenue Forecast In 2034 $3.82 billion
Growth Rate CAGR of 8.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Type, Technology Type, Procedure, Application Areas, End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Johnson & Johnson, Siemens Healthineers AG, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Hologic Inc., Teleflex Incorporated, Lantheus Holdings Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet S.A, Asahi Intecc Co. Ltd., AngioDynamics Inc., Sirtex Medical Limited., Delcath Systems Inc., ABK Biomedical Inc., Profound Medical Inc., IceCure Medical Ltd., Minimax Medical Holding Group.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Interventional Oncology Market Characteristics

3. Interventional Oncology Market Trends And Strategies

4. Interventional Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Interventional Oncology Growth Analysis And Strategic Analysis Framework

5.1. Global Interventional Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Interventional Oncology Market Growth Rate Analysis

5.4. Global Interventional Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Interventional Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Interventional Oncology Total Addressable Market (TAM)

6. Interventional Oncology Market Segmentation

6.1. Global Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Radiation Therapy Devices

Ablation Devices

Embolization Devices

6.2. Global Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ultrasound

Computed Tomography Guided

Magnetic Resonance-Guided

6.3. Global Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tumor Ablation

Tumor Biopsy

Vascular Interventions

Palliative Care

6.4. Global Interventional Oncology Market, Segmentation By Application Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Liver Cancer

Lung Cancer

Kidney Cancer

Pancreatic Cancer

Prostate Cancer

6.5. Global Interventional Oncology Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Research And Academic Institutions

6.6. Global Interventional Oncology Market, Sub-Segmentation Of Radiation Therapy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Linear Accelerators

Proton Therapy Systems

Brachytherapy Devices

6.7. Global Interventional Oncology Market, Sub-Segmentation Of Ablation Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Radiofrequency Ablation Devices

Microwave Ablation Devices

Cryoablation Devices

Irreversible Electroporation Systems

6.8. Global Interventional Oncology Market, Sub-Segmentation Of Embolization Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Microspheres

Coil Embolization Devices

Liquid Embolic Agents

Embolic Protection Devices

7. Interventional Oncology Market Regional And Country Analysis

7.1. Global Interventional Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Interventional Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Oncology Market

8.1. Asia-Pacific Interventional Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Oncology Market

9.1. China Interventional Oncology Market Overview

9.2. China Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Oncology Market

10.1. India Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Oncology Market

11.1. Japan Interventional Oncology Market Overview

11.2. Japan Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Oncology Market

12.1. Australia Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Oncology Market

13.1. Indonesia Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Oncology Market

14.1. South Korea Interventional Oncology Market Overview

14.2. South Korea Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Oncology Market

15.1. Western Europe Interventional Oncology Market Overview

15.2. Western Europe Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Oncology Market

16.1. UK Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Oncology Market

17.1. Germany Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Oncology Market

18.1. France Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Oncology Market

19.1. Italy Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Oncology Market

20.1. Spain Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Oncology Market

21.1. Eastern Europe Interventional Oncology Market Overview

21.2. Eastern Europe Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Oncology Market

22.1. Russia Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Oncology Market

23.1. North America Interventional Oncology Market Overview

23.2. North America Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Oncology Market

24.1. USA Interventional Oncology Market Overview

24.2. USA Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Oncology Market

25.1. Canada Interventional Oncology Market Overview

25.2. Canada Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Oncology Market

26.1. South America Interventional Oncology Market Overview

26.2. South America Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Oncology Market

27.1. Brazil Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Oncology Market

28.1. Middle East Interventional Oncology Market Overview

28.2. Middle East Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Oncology Market

29.1. Africa Interventional Oncology Market Overview

29.2. Africa Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Oncology Market Competitive Landscape And Company Profiles

30.1. Interventional Oncology Market Competitive Landscape

30.2. Interventional Oncology Market Company Profiles

30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Oncology Market Other Major And Innovative Companies

31.1. Terumo Corporation

31.2. Hologic Inc.

31.3. Teleflex Incorporated

31.4. Lantheus Holdings Inc.

31.5. Penumbra Inc.

31.6. Merit Medical Systems Inc.

31.7. Guerbet S.A

31.8. Asahi Intecc Co. Ltd.

31.9. AngioDynamics Inc.

31.10. Sirtex Medical Limited.

31.11. Delcath Systems Inc.

31.12. ABK Biomedical Inc.

31.13. Profound Medical Inc.

31.14. IceCure Medical Ltd.

31.15. Minimax Medical Holding Group

32. Global Interventional Oncology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Oncology Market

34. Recent Developments In The Interventional Oncology Market

35. Interventional Oncology Market High Potential Countries, Segments and Strategies

35.1 Interventional Oncology Market In 2029 - Countries Offering Most New Opportunities

35.2 Interventional Oncology Market In 2029 - Segments Offering Most New Opportunities

35.3 Interventional Oncology Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Interventional Oncology Market, Segmentation By Application Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Interventional Oncology Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Interventional Oncology Market, Sub-Segmentation Of Radiation Therapy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Interventional Oncology Market, Sub-Segmentation Of Ablation Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Interventional Oncology Market, Sub-Segmentation Of Embolization Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Interventional Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Interventional Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Johnson & Johnson Financial Performance
  • Table 80: Siemens Healthineers AG Financial Performance
  • Table 81: Stryker Corporation Financial Performance
  • Table 82: GE HealthCare Technologies Inc. Financial Performance
  • Table 83: Boston Scientific Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Interventional Oncology Market, Segmentation By Application Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Interventional Oncology Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Interventional Oncology Market, Sub-Segmentation Of Radiation Therapy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Interventional Oncology Market, Sub-Segmentation Of Ablation Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Interventional Oncology Market, Sub-Segmentation Of Embolization Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Interventional Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Interventional Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Johnson & Johnson Financial Performance
  • Figure 80: Siemens Healthineers AG Financial Performance
  • Figure 81: Stryker Corporation Financial Performance
  • Figure 82: GE HealthCare Technologies Inc. Financial Performance
  • Figure 83: Boston Scientific Corporation Financial Performance

Frequently Asked Questions

Interventional oncology is a medical specialty focused on minimally invasive, image-guided procedures to diagnose and treat cancer. Its primary purpose is to provide effective cancer treatment options with reduced recovery times and fewer side effects compared to traditional surgery. For further insights on this market, request a sample here

The market major growth driver - Increasing Prevalence Of Cancer Fueling The Growth Of The Market Due To Rising Lifestyle-Related Risk Factors And Growing Cancer Cases. For further insights on this market, request a sample here

The interventional oncology market size has grown strongly in recent years. It will grow from $2.49 billion in 2024 to $2.72 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing incidence of cancer worldwide, rising adoption of minimally invasive procedures, increasing healthcare expenditure in emerging economies, rising demand for image-guided therapies, and increasing awareness of interventional oncology benefits. The interventional oncology market size is expected to see strong growth in the next few years. It will grow to $3.82 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to rising demand for outpatient oncology procedures, growing use of combination therapies with immuno-oncology, increasing clinical trials for image-guided therapies, increasing access to interventional oncology in emerging markets, and the growing role of precision medicine in treatment planning. Major trends in the forecast period include advancement in image-guided ablation technologies, development of artificial intelligence-powered diagnostic tools, innovation in targeted drug-delivery systems, advancement in minimally invasive treatment devices, and development of personalized oncology treatment solutions. For further insights on this market, request a sample here

The interventional oncology market covered in this report is segmented
1) By Type: Radiation Therapy Devices, Ablation Devices, Embolization Devices
2) By Technology Type: Ultrasound, Computed Tomography Guided, Magnetic Resonance-Guided
3) By Procedure: Tumor Ablation, Tumor Biopsy, Vascular Interventions, Palliative Care
4) By Application Areas: Liver Cancer, Lung Cancer, Kidney Cancer, Pancreatic Cancer, Prostate Cancer
5) By End-Users: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutions Subsegments:
1) By Radiation Therapy Devices: Linear Accelerators, Proton Therapy Systems, Brachytherapy Devices
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Irreversible Electroporation Systems
3) By Embolization Devices: Microspheres, Coil Embolization Devices, Liquid Embolic Agents, Embolic Protection Devices For further insights on this market,
request a sample here

North America was the largest region in the interventional oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the interventional oncology market are Johnson & Johnson, Siemens Healthineers AG, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Hologic Inc., Teleflex Incorporated, Lantheus Holdings Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet S.A, Asahi Intecc Co. Ltd., AngioDynamics Inc., Sirtex Medical Limited., Delcath Systems Inc., ABK Biomedical Inc., Profound Medical Inc., IceCure Medical Ltd., Minimax Medical Holding Group. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Catheter-Based Therapy Enhances Precision In Liver Cancer Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon